We are L-Glutamic acid 5-methyl ester CAS:1499-55-4 manufacturer and supplier in China, Pls send inquiry of to firstname.lastname@example.org of visit www.nbinno.com our official website should you have any interests
Chemical Name:L-Glutamic acid 5-methyl ester
Molecular Formula: C6H11NO4
Molecular Weight: 161.15600
L-Glutamic acid γ-methyl ester
L-Glutamic acid 5-Methyl ester
Physical and Chemical Properties:
Density: 1.242 g / cm3
Boiling point: 316.1ºC at 760 mmHg
Melting point: 182 ° C (dec.) (Lit.)
Flash point: 145ºC
Refractive index: 29 ° (C = 2, 6mol / L HCl)
Appearance: White powder
Chloride content(Cl):Not more than 0.05%
Loss on Drying:Not more than 0.50%
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:2-8ºC.Keep the container tightly closed, put it in a tight dispenser, and store in a cool, dry place.
Application:L-Glutamic acid 5-methyl ester is a protected form of L-Glutamic acid. L-Glutamic acid is a nonessential amino acid that is important to the mammalian central nervous system. L-Glutamic acid is also a neurotransmitter for cone photoreceptors in the human brain and is used as a treatment for patients who have liver disease accompanied by encephalopathy (a condition termed ‘hepatic coma’).
Related News: Major global airports, including London Heathrow, are monitoring people arriving from China for signs of illness.1132832-75-7 Three more patients have been confirmed infected with coronavirus in South Korea, bringing the country’s total to 15, the South Korean Centers for Disease Control and Prevention (KCDC) announced in a press release.spiro[1-azabicyclo[2.2.2]octane-3,2'-oxirane] Three more patients have been confirmed infected with coronavirus in South Korea, bringing the country’s total to 15, the South Korean Centers for Disease Control and Prevention (KCDC) announced in a press release.5-Bromopyridine-2-carboxylic acid CAS:30766-11-1 Taking Minuo Huawei as an example, in 2016, the capacity utilization rate and production-sales ratio of its multiple drug substance varieties reached more than 90%. Therefore, domestic API companies have expanded their production capacity in recent years to meet the growing demand for APIs.It does not require a production license for the drug substance, and can be produced in an ordinary chemical plant. As long as it reaches a certain level, it can be used for the synthesis of the drug substance.